Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00160
Species: Homo sapiens
Position : chr14:23913940-23915344
Year: 2021
Title: Genetic Variation in Enhancers Modifies Cardiomyopathy Gene Expression and Progression.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Normal
PMID:  33478249
Tissue: heart left ventricle
Tissue Ontology ID: UBERON:0002084
Cell Source: HL-1 mouse atrial cardiomyocyte cell line
CVCL ID: CVCL_0303
Cell Type: cardiac muscle cell
Cell Ontology ID: CL:0000746
Experiment Type: Enhancer activity assay; regulatory variant functional assay; endogenous perturbation control
High Throughput Method: Promoter Capture Hi-C; H3K27ac ChIP-seq; ATAC-seq; H3K4me3 ChIP-seq; cardiac TF ChIP-seq; gnomAD variant filtering; GTEx eQTL analysis
Low Throughput Method: Dual-luciferase reporter assay of MYH7-C4-1; allele-specific luciferase assay; CRISPR/Cas9 C4-region deletion with no significant MYH6 or MYH7 expression effect; RT-qPCR; SDS-PAGE; reporter activity is positive but endogenous deletion did not support a required MYH7 enhancer role
About Target Gene
Target gene : MYH7
About TF
TF name : TBX5
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
TBX5 Physiological factors reactome 12
TBX5 YAP1- and WWTR1 (TAZ)-stimulated gene expression reactome 29
TBX5 Hs_Heart_Development_WP1591_90186 wikipathways 28
Enhancer Associated Network
Overlapping Enhancers (hg19) 3 found
Enhancer ID Position Tissue Cell Disease
E_00055 chr14:23913940-23915344 left cardiac ventricle ventricular cardiomyocyte cardiomyopathy
E_00159 chr14:23913940-23915344 heart left ventricle cardiac muscle cell NA
E_00056 chr14:23915187-23917391 left cardiac ventricle ventricular cardiomyocyte cardiomyopathy
Expression of Target Genes for the Enhancer